U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H12O6S
Molecular Weight 308.306
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SULISOBENZONE

SMILES

COC1=CC(O)=C(C=C1S(O)(=O)=O)C(=O)C2=CC=CC=C2

InChI

InChIKey=CXVGEDCSTKKODG-UHFFFAOYSA-N
InChI=1S/C14H12O6S/c1-20-12-8-11(15)10(7-13(12)21(17,18)19)14(16)9-5-3-2-4-6-9/h2-8,15H,1H3,(H,17,18,19)

HIDE SMILES / InChI

Description
Curator's Comment: Description was created using several sources including: https://www.ncbi.nlm.nih.gov/pubmed/?term=11407932; https://www.ncbi.nlm.nih.gov/pubmed/1729569; https://books.google.com/books?id=AmqJDAAAQBAJ&pg=PA209&lpg=PA209&dq=SULISOBENZONE+was+first+developed+by&source=bl&ots=RZpF_2Yj4K&sig=Cjei8l5DytTpZyrMSIYfMF3grtE&hl=en&sa=X&ved=0ahUKEwiKrPjK_KHPAhWFWT4KHXG4A6UQ6AEIOTAF#v=onepage&q=SULISOBENZONE%20was%20first%20developed%20by&f=false

Sulisobenzone (benzophenone-4) is an ingredient for use in sunscreens which protects the skin from damage by UVB and short-wave UVA ultraviolet light. The Food and Drug Administration (FDA) has approved the use of Benzophenone-4 as safe and effective, over-the-counter (OTC) sunscreen ingredient. Sulisobenzone is a subject to the FDA 2011 sunscreen final rule: it can be marketed without approved drug applications (without NDAs or ANDAs), must bear the statement of identity “sunscreen" and contain the information about SPF test. However it is said to be widely used in cosmetic products not labeled as sunscreens such as creams, moisturizers, shampoos and other hair care products, nail polish, lipsticks and lip balms. Sulisobenzone may cause contact dermatitis when used in cosmetics and toiletries. Benzophenone 4 is tested as 10%. It was reported that 10% sulisobenzone enhance skin penetration of the moderately lipophilic herbicide 2,4-D.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
BENEFIT TRIPLE PERFORMING FACIAL BROAD SPECTRUM SPF15

Approved Use

Helps prevent sunburn. Decreases the risk of skin cancer and early skin aging caused by the sun.
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
1.8 μg/g
0.1 mg single, topical
dose: 0.1 mg
route of administration: Topical
experiment type: SINGLE
co-administered:
SULISOBENZONE unknown
Rattus norvegicus
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
23.2 μg × h/mL
0.1 mg single, topical
dose: 0.1 mg
route of administration: Topical
experiment type: SINGLE
co-administered:
SULISOBENZONE unknown
Rattus norvegicus
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
9 h
0.1 mg single, topical
dose: 0.1 mg
route of administration: Topical
experiment type: SINGLE
co-administered:
SULISOBENZONE unknown
Rattus norvegicus
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Reactive oxygen species assay-based risk assessment of drug-induced phototoxicity: classification criteria and application to drug candidates.
2008 Aug 5
Development of colorimetric ozone detection papers with high ultraviolet resistance using ultraviolet absorbers.
2009 Jul
Solid-phase extraction followed by liquid chromatography-tandem mass spectrometry for the determination of hydroxylated benzophenone UV absorbers in environmental water samples.
2009 Nov 10
Development of a fully automated sequential injection solid-phase extraction procedure coupled to liquid chromatography to determine free 2-hydroxy-4-methoxybenzophenone and 2-hydroxy-4-methoxybenzophenone-5-sulphonic acid in human urine.
2010 Apr 7
The UV-absorber benzophenone-4 alters transcripts of genes involved in hormonal pathways in zebrafish (Danio rerio) eleuthero-embryos and adult males.
2011 Jan 15
Patents

Sample Use Guides

Apply sunscreen that contains Avobenzone 3.00% Octinoxate 7.49% Octocrylene 2.00% Sulisobenzone 1.50% liberally 15 minutes before sun exposure. Reapply at least every 2 hours. Children under 6 months of age: ask a doctor.
Route of Administration: Topical
After 1 hr incubation with five test concentrations of each chemical compound, epidermis was then exposed or not to UVA at a non-cytotoxic dose (50 J/sq cm). 18 hr after UVA exposure, cellular damage was evaluated measuring cytotoxicity by MTT conversion test.
Name Type Language
SULISOBENZONE
HSDB   INN   MART.   MI   USAN   USP   USP-RS   WHO-DD  
USAN   INN  
Official Name English
UVAL
Brand Name English
SYNTASE 230
Brand Name English
UVINUL MS 40
Brand Name English
2-HYDROXY-4-METHOXYBENZOPHENONE-5-SULFONIC ACID
Common Name English
SULISOBENZONE [USP-RS]
Common Name English
SULFISOBENZONE [VANDF]
Common Name English
Sulisobenzone [WHO-DD]
Common Name English
SULISOBENZONE [MI]
Common Name English
SULISOBENZONE [USAN]
Common Name English
UVINUL D 5030
Brand Name English
NSC-760350
Code English
SULISOBENZONE [MART.]
Common Name English
3-BENZOYL-4-HYDROXY-6-METHOXYBENZENESULFONIC ACID
Systematic Name English
UVASORB S 5
Brand Name English
SEESORB 101S
Brand Name English
SULISOBENZONE [USP MONOGRAPH]
Common Name English
BENZOPHENONE-4 [INCI]
Common Name English
MS 40
Brand Name English
SULFISOBENZONE
VANDF  
Common Name English
SULISOBENZONE [HSDB]
Common Name English
BENZENESULFONIC ACID, 5-BENZOYL-4-HYDROXY-2-METHOXY-
Common Name English
5-Benzoyl-4-hydroxy-2-methoxybenzenesulfonic acid
Systematic Name English
UVINUL MS-40
Brand Name English
VIOSORB 111
Brand Name English
ESCALOL 577
Brand Name English
SPECTRA-SORB UV 284
Brand Name English
NSC-60584
Code English
2-BENZOYL-5-METHOXY-1-PHENOL-4-SULFONIC ACID
Common Name English
BENZOPHENONE-4
INCI  
INCI  
Official Name English
SUNGARD
Brand Name English
sulisobenzone [INN]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 352.20
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
NCI_THESAURUS C851
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
CFR 21 CFR 352.10
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
Code System Code Type Description
EVMPD
SUB10746MIG
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
NSC
60584
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
CAS
4065-45-6
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
MERCK INDEX
m10383
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY Merck Index
SMS_ID
100000082932
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
DAILYMED
1W6L629B4K
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
WIKIPEDIA
SULISOBENZONE
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
ECHA (EC/EINECS)
223-772-2
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
INN
2098
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
RXCUI
1311567
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY RxNorm
PUBCHEM
19988
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
EPA CompTox
DTXSID2042436
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
HSDB
7422
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
MESH
C009361
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
FDA UNII
1W6L629B4K
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
ChEMBL
CHEMBL2059073
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
DRUG BANK
DB11185
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
RS_ITEM_NUM
1642100
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
NCI_THESAURUS
C74401
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
DRUG CENTRAL
3572
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY
NSC
760350
Created by admin on Fri Dec 15 15:14:46 UTC 2023 , Edited by admin on Fri Dec 15 15:14:46 UTC 2023
PRIMARY